High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer
, , , , , , , , e
16 giu 2017
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 16 giu 2017
Pagine: 324 - 330
Ricevuto: 17 gen 2017
Accettato: 14 mag 2017
DOI: https://doi.org/10.1515/raon-2017-0023
Parole chiave
© 2017 Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto
This work is licensed under the Creative Commons Attribution 4.0 International License.
Ono, Takashi
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Yabuuchi, Tomonori
Department of Radiation Oncology, Ninohe HospitalIwate, Japan
Nakamura, Tatsuya
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Kimura, Kanako
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Azami, Yusuke
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Hirose, Katsumi
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Suzuki, Motohisa
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Wada, Hitoshi
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Kikuchi, Yasuhiro
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Nemoto, Kenji
Department of Radiation Oncology, Yamagata University Faculty of MedicineYamagata, Japan